Prevalence of peripheral arterial disease in subject with a moderate risk of Cardiovascular (CV) disease (CVD) in primary prevention - PANDORA
Study identifier:NIS-CEU-DUM-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Prevalence of peripheral Arterial disease in subjects with a moderate CVD risk, with No overt vascular Diseases nOR diAbetes mellitus
Medical condition
Peripheral Arterial Disease (PAD)
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
9000
Study type
Observational
Age
45 Years +
Date
Study Start Date: 01 May 2007
Primary Completion Date: 01 Jul 2008
Study Completion Date: 01 Jul 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Subjects of either sex, any race, with at least two CVD risk factors, with no overt cardiovascular diseases nor diabetes mellitus | - |
Contacts
Investigators
Principal Investigator
Raffaele Sabia
AstraZeneca S.p.A.
